C V Jensen
Overview
Explore the profile of C V Jensen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
265
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bendix A, Jensen C, Bendix T
Clin Biomech (Bristol)
. 2013 Aug;
3(2):66-73.
PMID: 23915836
Sitting postures on a knee-support (Balans®) chair and a tiltable chair were investigated with 12 healthy subjects during office work and simulated assembly work. After at least 3 weeks' adaptation...
2.
Jensen C, Bendix T
Clin Biomech (Bristol)
. 2013 Aug;
7(2):87-90.
PMID: 23915684
Movement patterns in 10 healthy subjects sitting on an office chair with either a tiltable seat, a 5° forwards, or 5° backwards inclining seat were investigated; also the effect of...
3.
Lim E, Sellebjerg F, Jensen C, Altmann D, Grant D, Keir G, et al.
Mult Scler
. 2005 Oct;
11(5):532-6.
PMID: 16193890
The objectives of this study were (1) to determine how cerebrospinal fluid (CSF) neurofilament heavy chain (NfH(SM134) and NfH(SM135)) levels relate to clinical outcome in optic neuritis (ON) and multiple...
4.
Sellebjerg F, Jensen C, Larsson H, Frederiksen J
Mult Scler
. 2003 Mar;
9(1):102-7.
PMID: 12617276
Oral high-dose methylprednisolone treatment is efficacious in acute optic neuritis (ON) and attacks of multiple sclerosis (MS). The responses to treatment in subgroups of patients participating in two randomized, controlled...
5.
Sellebjerg F, Jensen J, Jensen C, Wiik A
Scand J Immunol
. 2002 Jul;
56(1):101-7.
PMID: 12100477
The pathogenetic role of autoantibodies in multiple sclerosis (MS) is uncertain. CD5+ B cells commonly produce autoantibodies, but CD5 expression has also been implicated in B-cell tolerance. We studied B-cell...
6.
Sellebjerg F, Giovannoni G, Hand A, Madsen H, Jensen C, Garred P
J Neuroimmunol
. 2002 Apr;
125(1-2):198-203.
PMID: 11960657
The role of nitric oxide (NO) in multiple sclerosis (MS) is not clear. We found increased cerebrospinal fluid concentrations of the NO degradation products nitrate (NO(x)) in clinically definite MS...
7.
Sorensen T, Sellebjerg F, Jensen C, Strieter R, Ransohoff R
Eur J Neurol
. 2002 Jan;
8(6):665-72.
PMID: 11784351
Studies of chemokines in cerebrospinal fluid (CSF) of patients with active multiple sclerosis (MS) have indicated that specific chemokines may have important roles in disease pathogenesis. We previously reported that...
8.
Blinkenberg M, Rune K, Jensen C, Ravnborg M, Kyllingsbaek S, Holm S, et al.
Ugeskr Laeger
. 2001 Jul;
163(27):3788-92.
PMID: 11466987
Introduction: Magnetic resonance imaging (MRI) lesion load is widely used in the clinical evaluation of patients with multiple sclerosis (MS), but little is known about the associated changes in cortical...
9.
Sellebjerg F, Jensen C, Christiansen M
J Neuroimmunol
. 2000 Jul;
108(1-2):207-15.
PMID: 10900355
We studied intrathecal IgG synthesis and autoantibody-secreting cells in 148 patients with possible onset symptoms of MS (POSMS) or clinically definite MS (CDMS). In POSMS intrathecal synthesis of IgG oligoclonal...
10.
Blinkenberg M, Rune K, Jensen C, Ravnborg M, Kyllingsbaek S, Holm S, et al.
Neurology
. 2000 Feb;
54(3):558-64.
PMID: 10680783
Objective: To study the association between the cortical cerebral metabolic rate of glucose (CMRglc), MRI T2-weighted total lesion area (TLA), cognitive dysfunction, and neurologic disability in MS. Background: MRI lesion...